Literature DB >> 8683520

The Canadian Familial Adenomatous Polyposis Registry: past, present and future.

H S Stern1.   

Abstract

The advent of the molecular world opening up for familial adenomatous polyposis and other genetically predisposed cancers has now provided us with wonderful tools to study these diseases. The challenges, however, clearly remain to transfer discoveries in the laboratory to improvements in the care of these patients.

Entities:  

Mesh：

Year:  1996        PMID： 8683520      PMCID： PMC1295701          DOI： 10.1177/014107689608900311

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


  7 in total

1.  Histopathological features of congenital fundus lesions in familial adenomatous polyposis.

Authors:  J A Parker; V I Kalnins; J H Deck; Z Cohen; T Berk; J B Cullen; A A Kiskis; W J Ke
Journal:  Can J Ophthalmol       Date:  1990-04       Impact factor: 1.882

2.  Familial polyposis and the role of the preventive registry.

Authors:  T Berk; Z Cohen; J B Cullen
Journal:  Can Med Assoc J       Date:  1981-06-01       Impact factor: 8.262

3.  Identification of somatic APC gene mutations in periampullary adenomas in a patient with familial adenomatous polyposis (FAP).

Authors:  B Bapat; R Odze; A Mitri; T Berk; M Ward; S Gallinger
Journal:  Hum Mol Genet       Date:  1993-11       Impact factor: 6.150

4.  Management of mesenteric desmoid tumours in familial adenomatous polyposis.

Authors:  T Berk; Z Cohen; R S McLeod; H S Stern
Journal:  Can J Surg       Date:  1992-08       Impact factor: 2.089

5.  The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.

Authors:  R Fishel; M K Lescoe; M R Rao; N G Copeland; N A Jenkins; J Garber; M Kane; R Kolodner
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

6.  Coping styles, psychopathology and intellectual performance in patients with familial adenomatous polyposis.

Authors:  A J Levitt; G Rodin; Z Cohen; T Berk
Journal:  Gen Hosp Psychiatry       Date:  1992-01       Impact factor: 3.238

7.  Combined use of molecular and biomarkers for presymptomatic carrier risk assessment in familial adenomatous polyposis: implications for screening guidelines.

Authors:  B V Bapat; J A Parker; T Berk; Z Cohen; R S McLeod; P N Ray; H S Stern
Journal:  Dis Colon Rectum       Date:  1994-02       Impact factor: 4.585
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.